US Patent 8012750 T-cell activation device
Patent 8012750 was granted and assigned to Immunovative Therapies on September, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 21 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+244 characters)
Article
Patent abstract
A biodegradable device for activating T-cells includes a biodegradable support and a binder attached to the biodegradable support, the binder having reactivity to one or more agents capable of binding to a T-cell surface antigen.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Michael Har-Noy0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08012750 T-cell activation device US Patent 8012750 T-cell activation device
Infobox
Patent Number
080127500
Patent Number
80127500
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080127500
Date of Patent
September 6, 2011
0Patent Application Number
125336680
Date Filed
July 31, 2009
0Patent Primary Examiner
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08012750 T-cell activation device
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08012750
Date of patent
September 6, 2011
Patent application number
12533668
Date Filed
July 31, 2009
Patent primary examiner
Find more entities like US Patent 8012750 T-cell activation device
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.